Data-driven mapping of known and novel fluid biomarker progression profiles in genetic frontotemporal lobar degeneration
Recent proteomic studies have identified both established and novel proteins in genetic frontotemporal lobar degeneration (FTLD). However, it remains unclear at what point in the disease these proteins deviate from normal levels and how their trajectories relate to one another. Defining the temporal sequence of p...